Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Harrison

Showing results (91-100 of 318) with videos related to

Pageof 32
Sort By:
Gastroenterology & Hepatology|December 31, 2016
Nonalcoholic Steatohepatitis and Endpoints in Clinical TrialsWilliam N Hannah, Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)|August 15, 2020
Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 PandemicNaim Alkhouri, Anita Kohli, Rohit Loomba, et al.
Diabetes, Obesity & Metabolism|March 21, 2024
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitisManal F Abdelmalek, Stephen A Harrison, Arun J Sanyal
Clinics in Liver Disease|May 1, 2012
Nonalcoholic fatty liver diseaseAngelo H Paredes, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|September 4, 2009
Effect of weight loss on nonalcoholic fatty liver diseaseAnish A Patel, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|April 4, 2012
Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?Jeremy P Domanski, Stephen J Park, Stephen A Harrison
The American Journal of Gastroenterology|November 12, 2002
Nonalcoholic steatohepatitis: what we know in the new millenniumStephen A Harrison, Shailesh Kadakia, Kevin A Lang, et al.
Digestive Diseases and Sciences|August 8, 2015
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US ExperienceRyan B Perumpail, Robert J Wong, Aijaz Ahmed, et al.
The American Journal of Gastroenterology|November 26, 2003
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitisStephen A Harrison, Sigurd Torgerson, Paul Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2023
Clinical Trial Landscape in NASHStephen A Harrison, Rohit Loomba, Julie Dubourg, et al.
Pageof 32

Showing results (91-100 of 318) with videos related to

Sort By:
Pageof 32
Gastroenterology & Hepatology|December 31, 2016
Nonalcoholic Steatohepatitis and Endpoints in Clinical TrialsWilliam N Hannah, Dawn M Torres, Stephen A Harrison
Hepatology (Baltimore, Md.)|August 15, 2020
Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 PandemicNaim Alkhouri, Anita Kohli, Rohit Loomba, et al.
Diabetes, Obesity & Metabolism|March 21, 2024
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitisManal F Abdelmalek, Stephen A Harrison, Arun J Sanyal
Clinics in Liver Disease|May 1, 2012
Nonalcoholic fatty liver diseaseAngelo H Paredes, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|September 4, 2009
Effect of weight loss on nonalcoholic fatty liver diseaseAnish A Patel, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|April 4, 2012
Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?Jeremy P Domanski, Stephen J Park, Stephen A Harrison
The American Journal of Gastroenterology|November 12, 2002
Nonalcoholic steatohepatitis: what we know in the new millenniumStephen A Harrison, Shailesh Kadakia, Kevin A Lang, et al.
Digestive Diseases and Sciences|August 8, 2015
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US ExperienceRyan B Perumpail, Robert J Wong, Aijaz Ahmed, et al.
The American Journal of Gastroenterology|November 26, 2003
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitisStephen A Harrison, Sigurd Torgerson, Paul Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2023
Clinical Trial Landscape in NASHStephen A Harrison, Rohit Loomba, Julie Dubourg, et al.
Pageof 32